PMC:5968208 / 5287-5807 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/5968208","sourcedb":"PMC","sourceid":"5968208","source_url":"https://www.ncbi.nlm.nih.gov/pmc/5968208","text":"Study performance\nOnly individuals who consented to participate in the study through a telephone call and gave written consent at the time of study initiation underwent surveys at local public health centers. Each participant responded to a questionnaire on exposure and provided a blood sample. Following the first serologic test by an enzymelinked immunospecific assay (ELISA), positive or borderline cases were tested using an immunofluorescence assay (IFA) and a plaque reduction neutralization antibody test (PRNT).","divisions":[{"label":"Title","span":{"begin":0,"end":17}}],"tracks":[]}